rxstat › Shortages › Clomipramine

Clomipramine shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Clomipramine is in a widespread shortage in Canada. 3 of 4 reported products are affected. The latest manufacturer estimate for full recovery is Jul 3, 2026.
Products affected
3 / 4
In shortage since
Jan 1, 2026
Est. full return
Jul 3, 2026
Reports on file
17
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · since Jun 2, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · since Mar 23, 2026, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · since Jan 1, 2026, est. end Jul 3, 2026 · Shortage of an active ingredient.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Apr 23, 2026 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Dec 22, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · ended Jan 31, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Jan 30, 2023 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Apr 1, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 17 reports. All reports are on file with Health Canada.

What's happening

Clomipramine is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC, TARO PHARMACEUTICALS INC.

The reported causes are: disruption of the manufacture of the drug; shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Clomipramine is classified under “ANTIDEPRESSANTS” (ATC N06AA).

Recent changes

Common questions

When will Clomipramine be back in stock in Canada?

The latest manufacturer estimate is Jul 3, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Clomipramine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antidepressants)

Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageBupropion3 of 15 reported products affected · est. return Jul 15, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026Partial shortageDoxepin1 of 11 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.